5.1 Congenital Heart Defects (Acyanotic vs. Cyanotic)

Congenital Heart Defects (CHD) in the Neonate

Understanding the pathophysiology of congenital heart defects (CHD) is a cornerstone of advanced neonatal nursing practice. The clinical presentation of these defects is heavily dependent on the transition from fetal to neonatal circulation, which determines how pulmonary vascular resistance (PVR) and systemic vascular resistance (SVR) interact.

Physiology of Transitional Circulation

In utero, the placenta serves as the organ of respiration. The fetal lungs are fluid-filled, causing mechanical compression of the pulmonary vessels, which, combined with hypoxic vasoconstriction, leads to high pulmonary vascular resistance (PVR). Only 8-10% of the right ventricular output enters the lungs; the remainder bypasses the lungs via the patent ductus arteriosus (PDA) and patent foramen ovale (PFO). At birth, umbilical cord clamping removes the low-resistance placental circuit, causing systemic vascular resistance (SVR) to rise. Simultaneously, lung expansion and oxygenation cause a dramatic decline in PVR. Failure of this transition or structural anomalies in these pathways results in congenital heart disease.

Acyanotic Congenital Heart Defects (Left-to-Right Shunting & Obstructive)

Acyanotic defects typically involve a left-to-right shunt where oxygenated blood flows from the high-pressure left side of the heart to the lower-pressure right side. The infant remains clinically pink with normal systemic saturations (95-100%), but is at risk for pulmonary overcirculation and congestive heart failure.

1. Ventricular Septal Defect (VSD)

The most common congenital heart defect, representing an opening in the ventricular septum.

• Pathophysiology: Shunting is minimal at birth due to high PVR. As PVR declines over the first 4-6 weeks of life, left-to-right shunting increases, leading to pulmonary congestion and left-sided volume overload.
• Clinical Presentation: A harsh, holosystolic murmur heard best at the lower left sternal border (LLSB). Symptoms of congestive heart failure (tachypnea, poor feeding, diaphoresis, failure to thrive) develop as the shunt increases.

2. Atrial Septal Defect (ASD)

An opening in the interatrial septum allowing left-to-right shunting at the atrial level.

• Pathophysiology: Left-to-right shunting leads to right atrial and right ventricular volume overload. PVR rarely rises significantly in infancy.
• Clinical Presentation: Often asymptomatic in neonates. May present with a soft systolic ejection murmur at the upper left sternal border (due to increased flow across the pulmonic valve) and a fixed, split second heart sound (S2).

3. Patent Ductus Arteriosus (PDA)

Persistence of the fetal connection between the descending aorta and the pulmonary artery. In term infants, it represents a structural defect in the ductal wall (elastic tissue deficiency). High aortic pressures force oxygenated blood back into the pulmonary circulation. Preterm presentation is detailed in Section 5.2.

4. Coarctation of the Aorta (CoA)

A localized narrowing of the aortic arch, usually located juxtaductal (near the ductus arteriosus). It represents an obstructive acyanotic lesion.

• Pathophysiology: Obstruction to left ventricular outflow. If the coarctation is severe, systemic perfusion is dependent on a patent ductus arteriosus (PDA) supplying the descending aorta (ductal-dependent systemic circulation). When the ductus closes, the infant develops severe hypoperfusion and cardiogenic shock.
• Clinical Presentation: A significant discrepancy in pulses and blood pressures between the upper and lower extremities. A systolic blood pressure difference of > 15-20 mmHg between the right arm (pre-ductal) and the lower extremities (post-ductal), along with absent or weak femoral pulses, is diagnostic.

Cyanotic Congenital Heart Defects (Right-to-Left Shunting & Mixed)

Cyanotic defects involve structural anomalies that restrict pulmonary blood flow or force deoxygenated systemic venous blood into the systemic circulation, resulting in systemic arterial desaturation (saturations typically 70-85%).

1. Transposition of the Great Arteries (TGA)

Ventriculoarterial discordance where the aorta arises from the right ventricle and the pulmonary artery arises from the left ventricle.

• Pathophysiology: Creates two parallel, non-communicating circulatory systems. Deoxygenated blood is recirculated to the body, and oxygenated blood is recirculated to the lungs. Survival is impossible without intercirculatory mixing via a PFO, ASD, or PDA.
• Clinical Presentation: Profound cyanosis within hours of birth that is completely unresponsive to supplemental oxygen. The classic chest radiograph shows an "egg on a string" cardiac silhouette due to a narrow superior mediastinum.
• Management: Emergency initiation of Prostaglandin E1 (PGE1) to maintain ductal patency, followed by a balloon atrial septostomy (Rashkind procedure) to optimize mixing at the atrial level before definitive surgical repair (Arterial Switch Operation).

2. Tetralogy of Fallot (TOF)

Consists of four features: a large ventricular septal defect (VSD), right ventricular outflow tract obstruction (pulmonary stenosis), an overriding aorta, and right ventricular hypertrophy.

• Pathophysiology: The degree of cyanosis depends on the severity of the pulmonary stenosis. If severe, right-to-left shunting occurs across the VSD, leading to severe hypoxia. Chest X-ray reveals a classic "boot-shaped" heart (coeur en sabot) due to right ventricular hypertrophy and a concave pulmonary waist.
• Hypercyanotic Spells ("Tet Spells"): Abrupt spasms of the infundibular septum triggered by crying, feeding, or defecation. This increases pulmonary resistance and drops systemic resistance, forcing deoxygenated blood across the VSD into the aorta.
• Tet Spell Management Protocol:
  1. Knee-chest positioning: Compresses femoral arteries, increasing systemic vascular resistance (SVR), which forces blood from the left ventricle through the pulmonary valve rather than shunting right-to-left.
  2. Calm the infant: Decreases sympathetic response and infundibular spasm.
  3. Oxygen: A potent pulmonary vasodilator and systemic vasoconstrictor.
  4. Morphine Sulfate (0.1 mg/kg IV/IM): Suppresses the respiratory center and relaxes the infundibular spasm.
  5. Volume expansion: 10 mL/kg of Normal Saline to maintain right ventricular preload.
  6. Esmolol or Propranolol: Beta-blockers to relax infundibular muscle spasm.

3. Hypoplastic Left Heart Syndrome (HLHS)

Severe underdevelopment of the left side of the heart, including mitral valve stenosis/atresia, a hypoplastic left ventricle, aortic valve stenosis/atresia, and hypoplasia of the ascending aorta.

• Pathophysiology: The left ventricle cannot support systemic circulation. The body is perfused entirely via right-to-left flow through the ductus arteriosus. As the ductus closes, systemic perfusion ceases, causing profound metabolic acidosis, shock, and death.
• Management: Continuous PGE1 infusion is mandatory. Surgical palliation is performed in three stages (Norwood, Glenn, Fontan) or via cardiac transplantation.

4. Tricuspid Atresia

Complete absence of the tricuspid valve, leading to a blind right atrium and a hypoplastic right ventricle.

• Pathophysiology: Systemic venous return must pass through an ASD/PFO to the left atrium, where it mixes with pulmonary venous return. Blood reaches the lungs via a VSD or a PDA. If the VSD is restrictive, pulmonary flow is ductal-dependent and requires PGE1.

Prostaglandin E1 (PGE1 / Alprostadil) Therapy

PGE1 is a continuous intravenous infusion used to maintain or reopen the ductus arteriosus in infants with ductal-dependent heart lesions.

• Dosing Guidelines:
  • Starting dose: 0.05 to 0.1 mcg/kg/min via a dedicated central line or secure peripheral IV.
  • Maintenance dose: Once ductal patency is established (evidenced by improved PaO2 or femoral pulses), the infusion is titrated down to 0.01 to 0.02 mcg/kg/min to minimize adverse reactions.
• Side Effects and Clinical Monitoring:
  • Apnea: The most critical side effect, occurring in up to 12% of infants, typically within the first two hours of initiation. Intubation equipment and ventilator support must be at the bedside before starting the infusion.
  • Systemic Vasodilation/Hypotension: Causes cutaneous flushing and a drop in blood pressure. Monitor blood pressure closely; have normal saline boluses ready.
  • Hyperthermia: Prostaglandins act on the hypothalamus, causing a benign fever.
  • Cortical Hyperostosis: Prolonged infusions (weeks to months) can cause subperiosteal new bone formation, presenting as limb pain and swelling.